Senior Member
|
|
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
|
|
Senior Member
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
|
I think the PPMI is an excellent idea. But, why is it only recruting PwP who are newly diagnosed and not on medication?
Using data from all PwP would not only give more data to analyse, good in itself, but also help at answering questions now, rather than in 10 years time, such as:
How does progression at 5 years compare to progression at 10 years?
Are progression markers at 10 years the same as for new patients?
What can we learn from long-term survivors?
John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
|